Objectives: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of in the diagnostic assessment of suspected tuberculosis in high-burden countries.
Methods: We conducted a retrospective, descriptive, cohort study among participants aged ≥ 18 years with suspected tuberculosis in Nanning, Guangxi, and China. Participants were tested for infection using commercially available antibodies against .
Talaromyces (Penicillium) marneffei can cause fatal disseminated infection in immunocompromised hosts. However, therapeutic strategies for the mycosis are limited. Reports of the other fungi suggest that berberine, a component of traditional herb, inhibitors interact with antifungal agents to improve the treatment outcomes.
View Article and Find Full Text PDF